Magnesium Sulfate Heptahydrate (Phebra) TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: magnesium sulfate
Brand name
(ARTG)
: Phebra MAGNESIUM SULFATE HEPTAHYDRATE 50% 2.5g/5mL injection vialDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
INDICATIONS AS AT 01 JAN 1991 : Parenteral administration of magnesium is indicated in the treatment of acute hypomagnesaemia. Magnesium salts are also indicated to prevent hypomagnesaemia in patients receiving total parenteral nutrition. Magnesium sulphate is also indicated in the prevention and treatment of life-threatening seizures in the treatment of toxemias of pregnancy (pre-eclampsia and eclampsia). For emegency treatment of some arrhythmias such as Torsade de Pointes and those associated with hypokalemia.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, concentrated
- Intramuscular
- Clear colourless solution
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is
- 10 x 5mL vials pack
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
